Volume 24, Number 10—October 2018
Dispatch
Invasive Pneumococcal Disease in Refugee Children, Germany
Table
Invasive pneumococcal disease in refugee children and German-born children, July 1, 2014–June 30, 2017*
IPD season |
No. patients |
Mean patient age, y |
No. (%) patients |
||||
Unvaccinated |
PCV13 vaccinated |
VT serotype |
Non-VT serotype |
Resistant to >3 classes of antimicrobial drugs |
|||
Refugee children in Germany | |||||||
2014–15 | 3 | 1 | 3 (100) | 0 | 2 (67) | 1 (33) | 1 (33) |
2015–16 | 12 | 3 | 10 (83) | 2 (17) | 8 (67) | 4 (33) | 4 (33) |
2016–17 | 6 | 5 | 5 (83) | 0 | 3 (50) | 3 (50) | 3 (50) |
Total |
21 |
3 |
18 (86) |
2 (9) |
13 (62) |
8 (38) |
8 (38) |
Germany-born children | |||||||
2014–15 | 107 | 2 | 19 (18) | 73 (68) | 28 (26) | 79 (74) | 5 (5) |
2015–16 | 122 | 2 | 21 (17) | 86 (70) | 19 (16) | 103 (84) | 1 (0.8) |
2016–17 | 176 | 3 | 45 (26) | 117 (66) | 28 (16) | 148 (84) | 4 (2) |
Total | 405 | 2 | 85 (21) | 276 (68) | 75 (19) | 330 (81) | 10 (2) |
*VT serotypes are 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5, 7F, 3, 6A, and 19A. Antimicrobial drug resistance is determined according to the 2015 breakpoints of the Clinical and Laboratory Standards Institute (11). IPD, invasive pneumococcal disease; PCV13, 13-valent pneumococcal conjugate vaccine; VT, vaccine type.
References
- Razum OS, Saß A-C, Bozorgmehr K. Gesundheitliche Versorgung von Geflüchteten: Herausforderungen und Lösungsansätze. Bundesgesundheitsblatt. 2016;59:543–4. DOIGoogle Scholar
- Wenner J, Razum O, Schenk L, Ellert U, Bozorgmehr K. Gesundheit von Kindern und Jugendlichen aus Familien mit ungesichertem Aufenthaltsstatus im Vergleich zu Kindern mit und ohne Migrationshintergrund: Auswertung der KiGGS-Daten 2003–06. Bundesgesundheitsblatt. 2016;59:627–35. DOIGoogle Scholar
- O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. DOIPubMedGoogle Scholar
- Nnadi C, Etsano A, Uba B, Ohuabunwo C, Melton M, Wa Nganda G, et al. Approaches to vaccination among populations in areas of conflict. J Infect Dis. 2017;216(suppl_1):S368–72. DOIPubMedGoogle Scholar
- World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2017 global summary [cited 2017 Sept 20]. http://apps.who.int/immunization_monitoring/globalsummary/schedules
- Grote U, Schleenvoigt BT, Happle C, Dopfer C, Wetzke M, Ahrenstorf G, et al. Norovirus outbreaks in german refugee camps in 2015. Z Gastroenterol. 2017;55:997–1003. DOIPubMedGoogle Scholar
- Kühne AG, Gilsdorf A. Ausbrüche von Infektionskrankheiten in Gemeinschaftsunterkünften für Asylsuchende 2004–2014 in Deutschland. Bundesgesundheitsblatt. 2016;59:570–7. DOIGoogle Scholar
- Robert Koch Institut. Konzept zur Umsetzung frühzeitiger Impfungen bei Asylsuchenden nach Ankunft in Deutschland. Epidemiologisches Bulletin. 2015;41:439–48.
- van der Linden M, Falkenhorst G, Perniciaro S, Fitzner C, Imöhl M. Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany. PLoS One. 2016;11:e0161257. DOIPubMedGoogle Scholar
- Imöhl M, Reinert RR, van der Linden M. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. Int J Med Microbiol. 2015;305:776–83. DOIPubMedGoogle Scholar
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement (M100-S25). Wayne (PA): The Institute; 2015.
- Heinze G. A comparative investigation of methods for logistic regression with separated or nearly separated data. Stat Med. 2006;25:4216–26. DOIPubMedGoogle Scholar
- Pavlopoulou IDT, Tanaka M, Dikalioti S, Samoli E, Nisianakis P, Boleti OD, et al. Clinical and laboratory evaluation of new immigrant and refugee children arriving in Greece. BMC Pediatr. 2017;17:132. DOIPubMedGoogle Scholar
- Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis. 2012;205:401–11. DOIPubMedGoogle Scholar
- Grijalva CG. Decrease in antibiotic use, an added benefit of PCVs. Lancet Infect Dis. 2014;14:175–7. DOIPubMedGoogle Scholar